secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001193125-23-213436
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Frequency Therapeutics terminates two leases, ending all lease obligations at 75 Hayden Ave by Jan 31, 2024 without cost
--------------------------------------------------------------------------------

- Terminated Master Lease with LS 75 Hayden LLC effective Jan 31, 2024 (originally through May 31, 2031).
- Terminated Sublease with Saliogen Therapeutics effective Jan 31, 2024 (originally through July 31, 2024).
- Company is not subject to any payments or costs under either termination agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523213436/0001193125-23-213436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312523213436/d493024d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-213436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer